{"created":"2023-05-15T11:20:50.299836+00:00","id":3924,"links":{},"metadata":{"_buckets":{"deposit":"db8a4acf-ca8e-477e-848d-7f61f53d6d48"},"_deposit":{"created_by":1,"id":"3924","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"3924"},"status":"published"},"_oai":{"id":"oai:ir.jikei.ac.jp:00003924","sets":["25:51:204:214"]},"author_link":["48269","19098","48277","48263","48272","48266","50652","38810","48281","48260","15898","48257","48268","48259","48278","78178","48275"],"item_16_alternative_title_1":{"attribute_name":"タイトル･ヨミ","attribute_value_mlt":[{"subitem_alternative_title":"ゲムシタビン　ニ　ヨル　HER2　ハツゲン　ゾウキョウ　コウカ　オ　リヨウシタ　スイガン　ニ　タイスル　アラタナ　ブンシ　ヒョウテキ　リョウホウ　ダイ131カイ　セイイカイ　ソウカイ　イッパン　エンダイ"}]},"item_16_alternative_title_3":{"attribute_name":"別タイトル","attribute_value_mlt":[{"subitem_alternative_title":"Up-regulation of human epidermal growth factor receptor 2 by gemcitabinie augments the antitumor effect of trastuzumab emtansine against gemcitabine-treated pancreatic cancer"}]},"item_16_biblio_info_27":{"attribute_name":"雑誌名","attribute_value_mlt":[{"bibliographicIssueNumber":"6","bibliographicPageEnd":"205","bibliographicPageStart":"205","bibliographicVolumeNumber":"129","bibliographic_titles":[{"bibliographic_title":"東京慈恵会医科大学雑誌"}]}]},"item_16_date_20":{"attribute_name":"刊行年月","attribute_value_mlt":[{"subitem_date_issued_datetime":"2014-11-15","subitem_date_issued_type":"Issued"}]},"item_16_relation_28":{"attribute_name":"情報源","attribute_value_mlt":[{"subitem_relation_name":[{"subitem_relation_name_text":"The Jikei University School of Medicine"}]}]},"item_16_rights_31":{"attribute_name":"著作権関連情報","attribute_value_mlt":[{"subitem_rights":"The Jikei University School of Medicine"}]},"item_16_select_22":{"attribute_name":"国立情報学研究所 メタデータ主題語彙集（資源タイプ）","attribute_value_mlt":[{"subitem_select_item":"Article"}]},"item_16_source_id_25":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0375-9172","subitem_source_identifier_type":"ISSN"}]},"item_16_source_id_26":{"attribute_name":"書誌レコードID（総合目録DB）","attribute_value_mlt":[{"subitem_source_identifier":"AN0016049X","subitem_source_identifier_type":"NCID"}]},"item_16_text_16":{"attribute_name":"著者所属","attribute_value_mlt":[{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部"},{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部, 東京慈恵会医科大学附属柏病院消化器・肝臓内科"},{"subitem_text_value":"北里大学薬学部先端免疫治療学講座"},{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部, 東京慈恵会医科大学内科学講座腫瘍・血液内科"},{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部"},{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部"},{"subitem_text_value":"東京慈恵会医科大学附属病院新橋健診センター"},{"subitem_text_value":"東京慈恵会医科大学内科学講座腫瘍・血液内科"},{"subitem_text_value":"東京慈恵会医科大学総合医学研究センター悪性腫瘍治療研究部"}]},"item_16_version_type_44":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_be7fb7dd8ff6fe43","subitem_version_type":"NA"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"闞, 鑫"}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"小井戸, 薫雄","creatorNameLang":"ja"},{"creatorName":"コイド, シゲオ","creatorNameLang":"ja-Kana"},{"creatorName":"Koido, Shigeo","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{},{}]},{"creatorNames":[{"creatorName":"岡本, 正人"}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"林, 和美"}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"伊藤, 正紀","creatorNameLang":"ja"},{"creatorName":"イトウ, マサキ","creatorNameLang":"ja-Kana"},{"creatorName":"Ito, Masaki","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"鎌田, 裕子","creatorNameLang":"ja"},{"creatorName":"カマタ, ユウコ","creatorNameLang":"ja-Kana"},{"creatorName":"Kamata, Yuko","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorNames":[{"creatorName":"込田, 英夫"}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"永崎, 栄次郎","creatorNameLang":"ja"},{"creatorName":"ナガサキ, エイジロウ","creatorNameLang":"ja-Kana"},{"creatorName":"Nagasaki, Eijiro","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]},{"creatorAffiliations":[{"affiliationNameIdentifiers":[{"affiliationNameIdentifier":""}],"affiliationNames":[{"affiliationName":""}]}],"creatorNames":[{"creatorName":"本間, 定","creatorNameLang":"ja"},{"creatorName":"ホンマ, サダム","creatorNameLang":"ja-Kana"},{"creatorName":"Homma, Sadamu","creatorNameLang":"en"}],"familyNames":[{},{},{}],"givenNames":[{},{},{}],"nameIdentifiers":[{}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-07-02"}],"displaytype":"detail","filename":"129-6-199.pdf","filesize":[{"value":"1.4 MB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"129-6-199.pdf","url":"https://ir.jikei.ac.jp/record/3924/files/129-6-199.pdf"},"version_id":"f0f2beb9-1d16-47c7-a20a-45c75635058b"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"ゲムシタビンによるHER2発現増強効果を利用した膵癌に対する新たな分子標的療法 (第131回成医会総会一般演題)","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"ゲムシタビンによるHER2発現増強効果を利用した膵癌に対する新たな分子標的療法 (第131回成医会総会一般演題)"},{"subitem_title":"ゲムシタビンによるHER2発現増強効果を利用した膵癌に対する新たな分子標的療法 (第131回成医会総会一般演題)","subitem_title_language":"en"}]},"item_type_id":"16","owner":"1","path":["214"],"pubdate":{"attribute_name":"公開日","attribute_value":"2015-01-27"},"publish_date":"2015-01-27","publish_status":"0","recid":"3924","relation_version_is_last":true,"title":["ゲムシタビンによるHER2発現増強効果を利用した膵癌に対する新たな分子標的療法 (第131回成医会総会一般演題)"],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2024-02-06T01:19:13.131080+00:00"}